Current and historical daily PE Ratio for Biocon Ltd (
NSE:BIOCON
) from 2004 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biocon stock (NSE:BIOCON) PE ratio as of Jun 06 2024 is 38.01.
More Details
Biocon Ltd (NSE:BIOCON) PE Ratio (TTM) Chart
Biocon Ltd (NSE:BIOCON) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 1293
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Biocon PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-06 | 35.7 | 2024-04-04 | 31.6 |
| 2024-06-04 | 34.1 | 2024-04-03 | 31.9 |
| 2024-06-03 | 36.3 | 2024-04-02 | 31.6 |
| 2024-05-31 | 36.2 | 2024-04-01 | 31.6 |
| 2024-05-30 | 36.4 | 2024-03-29 | 30.9 |
| 2024-05-29 | 37.9 | 2024-03-28 | 30.9 |
| 2024-05-28 | 37.2 | 2024-03-27 | 25.6 |
| 2024-05-27 | 36.9 | 2024-03-26 | 25.7 |
| 2024-05-24 | 37.4 | 2024-03-25 | 25.1 |
| 2024-05-23 | 36.9 | 2024-03-22 | 25.1 |
| 2024-05-22 | 36.1 | 2024-03-21 | 24.8 |
| 2024-05-21 | 36.0 | 2024-03-20 | 24.6 |
| 2024-05-20 | 35.8 | 2024-03-19 | 24.5 |
| 2024-05-18 | 35.7 | 2024-03-18 | 25.0 |
| 2024-05-17 | 35.8 | 2024-03-15 | 25.1 |
| 2024-05-16 | 35.8 | 2024-03-14 | 26.7 |
| 2024-05-15 | 36.5 | 2024-03-13 | 25.2 |
| 2024-05-14 | 36.4 | 2024-03-12 | 26.9 |
| 2024-05-13 | 35.3 | 2024-03-11 | 27.8 |
| 2024-05-10 | 35.6 | 2024-03-08 | 28.1 |
| 2024-05-09 | 35.0 | 2024-03-07 | 28.1 |
| 2024-05-08 | 36.0 | 2024-03-06 | 27.4 |
| 2024-05-07 | 34.5 | 2024-03-05 | 27.9 |
| 2024-05-06 | 35.2 | 2024-03-04 | 27.8 |
| 2024-05-03 | 35.7 | 2024-03-01 | 27.3 |
| 2024-05-02 | 36.4 | 2024-02-29 | 27.6 |
| 2024-05-01 | 35.0 | 2024-02-28 | 27.0 |
| 2024-04-30 | 35.0 | 2024-02-27 | 27.5 |
| 2024-04-29 | 35.9 | 2024-02-26 | 27.2 |
| 2024-04-26 | 35.9 | 2024-02-23 | 27.2 |
| 2024-04-25 | 34.1 | 2024-02-22 | 27.0 |
| 2024-04-24 | 33.9 | 2024-02-21 | 27.3 |
| 2024-04-23 | 32.8 | 2024-02-20 | 28.0 |
| 2024-04-22 | 31.8 | 2024-02-19 | 29.0 |
| 2024-04-19 | 30.6 | 2024-02-16 | 28.6 |
| 2024-04-18 | 31.3 | 2024-02-15 | 27.4 |
| 2024-04-17 | 30.9 | 2024-02-14 | 27.1 |
| 2024-04-16 | 30.9 | 2024-02-13 | 26.6 |
| 2024-04-15 | 31.1 | 2024-02-12 | 26.6 |
| 2024-04-12 | 32.1 | 2024-02-09 | 27.3 |
| 2024-04-11 | 32.6 | 2024-02-08 | 28.4 |
| 2024-04-10 | 32.6 | 2024-02-07 | 28.9 |
| 2024-04-09 | 31.8 | 2024-02-06 | 29.8 |
| 2024-04-08 | 32.1 | 2024-02-05 | 28.4 |
| 2024-04-05 | 31.7 | 2024-02-02 | 27.4 |
Biocon Ltd (NSE:BIOCON) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biocon Ltd
ISIN : INE376G01013
Share Class Description:
NSE:BIOCON: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIOCON.India IPO Date
2004-04-07Description
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers